Using evolutionary constraint to define novel candidate driver genes in medulloblastoma
Roy, A.; Sakthikumar, S.; Kozyrev, S. V.; Nordin, J.; Pensch, R.; Pettersson, M. E.; Karlsson, E.; Lindblad-Toh, K.; Forsberg-Nilsson, K.
Show abstract
Current knowledge of cancer genomics is biased against non-coding mutations. Here, we use whole genome sequencing data from pediatric brain tumors, combined with evolutionary constraint inferred from 240 mammals to identify genes enriched in non-coding constraint mutations (NCCMs). We compare medulloblastoma (MB, malignant) to pilocytic astrocytoma (PA, benign) and find drastically different NCCM frequencies between the two. In PA, a high NCCM frequency only affects the BRAF locus, while in MB, >500 genes have high levels of NCCMs. Intriguingly, many genes are associated with different age of onset, such as HOXB1 in young patients and NUAK1 in adult patients. Our analysis points to different molecular pathways in different patient groups. These novel candidate driver genes may assist patient stratification in MB and may be useful for treatment options. One-Sentence SummaryNon-coding constraint mutations implicate novel candidate genes to stratify medulloblastoma by age and subgroups.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers 95%
- Tumor to normal single cell mRNA comparisons reveal a pan-neuroblastoma cancer cell 94%
- Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug resistant gliomas 94%
Similar papers in this journal
- Systematic analysis of genetic and phenotypic characteristics reveals antisense oligonucleotide therapy potential for one-third of neurodevelopmental disorders 94%
- Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition 93%
- Multi-scale characterisation of homologous recombination deficiency in breast cancer 93%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.